This is a preview of subscription content, log in via an institution to check access.
Notes
Evaluating Adverse Events in a Global Smoking Cessation Study
The study was funded by Pfizer Inc, New York, US.
Reference
Baker CL, et al. A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial. ClinicoEconomics and Outcomes Research : 19 Jan 2018. Available from: URL: https://doi.org/10.2147/CEOR.S153897
Rights and permissions
About this article
Cite this article
Varenicline for smoking cessation: better outcomes at lower cost. PharmacoEcon Outcomes News 795, 35 (2018). https://doi.org/10.1007/s40274-018-4673-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4673-0